Nature Reviews Nephrology

Papers
(The H4-Index of Nature Reviews Nephrology is 62. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Genetics of diabetes mellitus and diabetes complications623
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup429
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19404
Kidney involvement in COVID-19 and rationale for extracorporeal therapies342
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality264
Pathophysiology of COVID-19-associated acute kidney injury260
The current and future landscape of dialysis235
Autophagy in kidney homeostasis and disease233
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors231
The immunology of renal cell carcinoma213
The tubular hypothesis of nephron filtration and diabetic kidney disease209
Mitochondrial quality control in kidney injury and repair204
The impact of chronic kidney disease on global health196
Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic195
WNT–β-catenin signalling — a versatile player in kidney injury and repair193
Cellular senescence: the good, the bad and the unknown184
Hypertension-induced cognitive impairment: from pathophysiology to public health181
Plant-based diets to manage the risks and complications of chronic kidney disease148
Mechanisms of cognitive dysfunction in CKD146
Mental health of health-care workers in the COVID-19 era145
CKD is a key risk factor for COVID-19 mortality139
Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection129
Digital pathology and computational image analysis in nephropathology129
Randall’s plaque and calcium oxalate stone formation: role for immunity and inflammation128
Determining the true burden of kidney stone disease124
Food as medicine: targeting the uraemic phenotype in chronic kidney disease123
Trajectories of kidney function in diabetes: a clinicopathological update123
COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19119
The effect of HIF on metabolism and immunity105
Nitric oxide signalling in kidney regulation and cardiometabolic health102
Complexities of the glomerular basement membrane99
COVID-19 vaccination in kidney transplant recipients98
Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease96
Sustainable Development Goals relevant to kidney health: an update on progress94
Integrated multi-omics approaches to improve classification of chronic kidney disease93
Multi-omics integration in the age of million single-cell data93
Genomic profiling in renal cell carcinoma92
Impact of the COVID-19 pandemic on clinical research88
Postoperative acute kidney injury in adult non-cardiac surgery: joint consensus report of the Acute Disease Quality Initiative and PeriOperative Quality Initiative88
Epidemiology of haemodialysis outcomes87
Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence85
The fibrogenic niche in kidney fibrosis: components and mechanisms85
Mineralocorticoid receptor antagonists in diabetic kidney disease — mechanistic and therapeutic effects84
Organ donation and transplantation: a multi-stakeholder call to action84
Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation84
Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function83
COVID-19 vaccines and kidney disease83
Cisplatin nephrotoxicity: new insights and therapeutic implications82
COVID-19: implications for immunosuppression in kidney disease and transplantation79
The COVID-19 pandemic: consequences for nephrology77
Minimizing the risk of COVID-19 among patients on dialysis76
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup73
Targeting angiogenesis and lymphangiogenesis in kidney disease73
Association of metabolic dysfunction-associated fatty liver disease with kidney disease70
Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury70
Conversion of extracellular ATP into adenosine: a master switch in renal health and disease69
Tools for the analysis of high-dimensional single-cell RNA sequencing data68
Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations66
Circular RNAs in kidney disease and cancer64
Immunopathophysiology of trauma-related acute kidney injury63
Therapeutic advances in COVID-1963
Health inequities and the inappropriate use of race in nephrology63
Extracellular vesicles in kidney disease62
0.034329891204834